Why True Biological Ageing Requires Solutions That Penetrate Below the Epidermis

Many patients searching for aesthetic treatments begin their journey with a straightforward question: why isn't my skincare working as well as I hoped? Despite diligently applying serums, moisturisers, and SPF, visible signs of ageing — fine lines, loss of firmness, hollowing, and uneven texture — can persist and deepen over time. This leads many people to research deeper interventions and to ask whether topical products are ever truly enough.

The honest answer lies in the biology of skin ageing itself. Biological skin ageing begins below the epidermis — in the dermis and deeper structural layers — where collagen, elastin, hyaluronic acid, and supporting tissues gradually break down. Because the epidermis acts as a formidable barrier, the majority of topical products simply cannot reach these deeper layers in sufficient concentrations to meaningfully reverse what is occurring beneath.

This article explores why sub-epidermal skin ageing is the central challenge in aesthetic medicine, what the science tells us about how ageing progresses through the skin's layers, and why certain professional treatments are designed to address the dermis and deeper tissues directly. As with any aesthetic consideration, individual suitability should always be assessed during a professional consultation.

Sub-epidermal skin ageing — the breakdown of collagen, elastin, and hyaluronic acid within the dermis — is the primary driver of visible wrinkles, volume loss, and sagging. Because the epidermis acts as a protective barrier, most topical products cannot penetrate deeply enough to stimulate meaningful structural repair. Professional aesthetic treatments are designed to reach the dermal and sub-dermal layers where biological ageing originates.

To appreciate why sub-epidermal ageing is so clinically significant, it helps to understand the basic structure of human skin.

The skin is broadly divided into three layers:

The epidermis — the outermost layer, responsible for barrier function, surface texture, and pigmentation. The dermis — the middle layer, rich in collagen, elastin, and hyaluronic acid. This is where structural support, firmness, and hydration are primarily maintained. The hypodermis (subcutaneous layer) — the deepest layer, comprising fat and connective tissue that provides volume, contour, and insulation.

The epidermis is a remarkably effective biological barrier — and rightly so. It exists to prevent pathogens, toxins, and environmental damage from penetrating the body. However, this same barrier function means that even well-formulated topical products face significant limitations in reaching the dermis.

For patients exploring anti-ageing treatments, this matters considerably. If the structural drivers of facial ageing — collagen fragmentation, elastin degradation, volume loss — are occurring beneath the epidermis, then treatments targeting only the epidermal surface are unlikely to produce lasting structural improvement. Understanding this distinction helps patients ask better questions during consultations and set more realistic expectations.

Sub-epidermal skin ageing is not a single event but a complex, ongoing biological process influenced by both intrinsic (internal) and extrinsic (external) factors.

Collagen Degradation

Collagen is the primary structural protein of the dermis, providing tensile strength and firmness to the skin. From the mid-twenties onwards, the body's natural collagen synthesis gradually declines — estimated at approximately 1% per year. Simultaneously, environmental factors such as ultraviolet (UV) radiation accelerate the activity of enzymes called matrix metalloproteinases (MMPs), which break down existing collagen fibres.

The result is a progressively thinner, less resilient dermis. Skin begins to sag, fine lines deepen into wrinkles, and the face loses definition.

Elastin Loss and Reduced Skin Recoil

Elastin fibres give skin its elasticity — the ability to return to its original shape after movement or compression. Elastin production largely ceases in adulthood, and existing fibres degrade over time due to UV exposure, oxidative stress, and natural cellular ageing. This is why older skin does not spring back as readily as younger skin and why expression lines can become permanently etched.

Hyaluronic Acid Depletion

Hyaluronic acid (HA) is a naturally occurring molecule found throughout the dermis that binds water molecules and contributes to skin plumpness, hydration, and resilience. With age, endogenous HA production decreases and existing molecules are broken down more rapidly. This results in a loss of dermal volume, increased dryness, and a flattening of the facial contours that many patients find concerning.

Facial Volume Loss and Structural Change

Ageing also involves changes to deeper structures: fat compartments of the face deflate and descend, bone resorption alters the facial skeleton, and the supporting ligaments of the face weaken. These changes in the sub-dermal and skeletal frameworks contribute significantly to the overall appearance of facial ageing — and cannot be addressed by surface-level treatments alone.

This is not a dismissal of topical skincare — a well-designed routine incorporating SPF, antioxidants, and evidence-backed ingredients such as retinoids and peptides provides genuine benefit for epidermal health, surface texture, and prevention of further UV damage.

However, even the most advanced serums face a fundamental physicochemical challenge: molecular size and skin penetration. The epidermis permits very limited absorption of large molecules — and many of the actives associated with dermal repair (including intact collagen and high-molecular-weight hyaluronic acid) are simply too large to cross the epidermal barrier in clinically meaningful amounts.

Retinoids represent one of the most evidence-supported topical ingredients, capable of stimulating collagen synthesis and influencing skin cell turnover. Yet even retinoids, while demonstrably beneficial at the epidermal level, produce relatively modest structural changes in the dermis compared to injectable or energy-based professional treatments.

This biological reality does not mean topical skincare is without value. Rather, it means that patients with visible signs of dermal or sub-dermal ageing may benefit from discussing professional treatment options alongside their skincare routine.

A number of aesthetic treatments have been developed specifically to bypass epidermal limitations and deliver their effects at the dermal or sub-dermal level.

Injectable Dermal Fillers

Dermal fillers are typically formulated with hyaluronic acid and are injected directly into the dermis or sub-dermal tissues to restore volume, soften lines, and improve facial contours. By introducing HA at the level where it is naturally depleted, fillers address the biological deficit more directly than topical HA products can.

Results depend on the type of filler used, the area treated, the individual's anatomy, and the technique of the treating practitioner. Longevity varies and repeat treatments are typically required to maintain results. Risks and suitability should always be discussed in a professional consultation.

Polynucleotide (PDRN) Treatments

Polynucleotide treatments involve the injection of highly purified DNA fragments derived from marine sources. These molecules work at the cellular level within the dermis, where they are thought to stimulate fibroblast activity, supporting the skin's natural capacity to produce collagen and elastin. Polynucleotides represent a biostimulatory approach — working with the skin's own regenerative mechanisms rather than simply adding volume.

Research into polynucleotide therapy in aesthetic medicine is growing, and many practitioners are incorporating it into treatment plans for skin quality improvement. As with all injectable treatments, individual responses vary, and a thorough suitability assessment is essential.

Jalupro and Amino Acid-Based Bio-Revitalisers

Jalupro and similar bio-revitalising treatments combine hyaluronic acid with amino acids and other dermal nutrients delivered via intradermal injection. The aim is to nourish the fibroblasts within the dermis directly, supporting the skin's natural collagen production processes. These treatments are often used to address skin quality, hydration, and early structural decline rather than significant volume loss.

Professional assessment is appropriate for individuals who have noticed changes in their skin or facial appearance that are not adequately addressed by skincare alone, or who wish to explore evidence-informed aesthetic options. This might include:

Deepening lines and wrinkles that persist at rest, suggesting dermal collagen loss rather than simple surface dehydration. Loss of facial volume or contour — particularly in the cheeks, temples, or under-eye area — that reflects sub-dermal fat and structural changes. Reduced skin firmness and elasticity, where the skin appears less resilient or has a crepey texture. Persistent skin dullness or uneven texture that does not respond adequately to topical treatments. A general interest in skin quality improvement and a desire to understand the full range of available options.

A consultation with a qualified aesthetic practitioner does not commit anyone to treatment. It is an opportunity to receive personalised information, understand what options may or may not be appropriate, and make an informed decision. Treatment suitability varies significantly between individuals and should always be determined through thorough individual assessment.

It is important for patients to approach sub-epidermal aesthetic treatments with balanced, realistic expectations.

Potential benefits of professionally administered injectable or energy-based treatments may include:

Restoration of volume in areas affected by fat compartment depletion Improved skin hydration and dermal density Reduction in the appearance of lines and wrinkles Support for the skin's natural collagen-producing processes Improved facial contour and definition

Limitations and important considerations include:

Results are not permanent. Most injectable treatments require maintenance at intervals determined by the product used, the area treated, and individual metabolism. Responses vary considerably between patients. Factors such as age, skin condition, lifestyle, sun damage history, and individual anatomy all influence outcomes. Injectable treatments carry risks, including bruising, swelling, asymmetry, and in rare cases more serious complications. These should be discussed thoroughly prior to any procedure. No aesthetic treatment can fully reverse the biological process of ageing, nor prevent its continuation. The best outcomes are generally achieved through a holistic approach that combines professional treatments, evidence-based skincare, sun protection, and healthy lifestyle habits.

Regardless of which aesthetic pathway a patient chooses, supporting the skin's health through consistent daily habits forms an essential foundation.

Sun protection is arguably the single most impactful preventive measure available. UV radiation is the primary driver of extrinsic (photoageing) skin damage and accelerates collagen and elastin breakdown. A broad-spectrum SPF 30 or higher should be applied daily, year-round, even in the UK climate.

Hydration, both topical and systemic, supports epidermal barrier function and general skin health. Drinking adequate water and using an appropriate moisturiser for your skin type helps maintain surface comfort and resilience.

Retinoids (including prescription tretinoin and over-the-counter retinol) remain among the most evidence-backed topical ingredients for supporting collagen synthesis and encouraging healthy skin cell turnover. A dermatologist or qualified aesthetic practitioner can advise on appropriate formulations and concentrations for individual skin types.

Antioxidant-rich skincare — particularly topical vitamin C — can help neutralise free radical damage and support collagen stability.

Post-treatment aftercare for injectable procedures typically includes avoiding strenuous exercise, sun exposure, and alcohol for a period advised by the treating practitioner. Specific aftercare instructions vary by treatment and should always be followed carefully.

Biological skin ageing originates primarily in the dermis and deeper structures, where collagen, elastin, and hyaluronic acid gradually break down — processes that topical products have limited ability to address directly. The epidermis acts as a barrier, restricting the penetration of many topical actives to the deeper dermal layers where structural ageing occurs. Professional injectable and bio-stimulatory treatments are designed to work below the epidermis, directly addressing dermal depletion and supporting the skin's natural repair mechanisms. Realistic expectations are essential — no treatment reverses ageing entirely, and results vary significantly between individuals. A holistic approach combining professional treatments, evidence-based skincare, and sun protection generally produces the most sustained benefit. Individual suitability for any aesthetic treatment must be assessed by a qualified practitioner during a professional consultation.

Can topical skincare products reach the dermis?

Most topical products are formulated to work at the epidermal level and have limited penetration into the dermis due to the skin's barrier function. Some ingredients — such as retinoids and certain low-molecular-weight compounds — can exert influence on the upper dermis, but the degree of structural change achievable through topical application alone is considerably more modest than that achievable through professionally administered injectable or energy-based treatments. A qualified aesthetic practitioner can advise on the most appropriate combination approach for individual needs.

What is the difference between skin quality treatments and volume-replacement treatments?

Volume-replacement treatments — such as certain hyaluronic acid dermal fillers — are primarily intended to restore lost volume and structural support in areas of the face that have become deflated or hollow with age. Skin quality treatments — such as polynucleotides or bio-revitalisers — focus on improving the biological environment of the dermis, supporting collagen and elastin production and improving hydration, texture, and overall skin quality. These approaches are not mutually exclusive and are often used in combination as part of a tailored treatment plan.

How long do results from injectable dermal treatments typically last?

Longevity varies considerably depending on the type of product used, the treatment area, the individual's age, metabolism, lifestyle factors, and how the treatment was administered. Hyaluronic acid fillers may last anywhere from six months to two years or more in some areas. Biostimulatory treatments such as polynucleotides may require a course of initial sessions followed by periodic maintenance. A practitioner will discuss expected longevity during the consultation process, and it is important to understand that results are not permanent.

Are injectable aesthetic treatments safe?

When administered by appropriately trained and qualified practitioners working within a regulated clinical environment, injectable aesthetic treatments have an established safety profile. However, all medical interventions carry potential risks. Common side effects include bruising, swelling, and temporary tenderness at the injection site. More serious complications, whilst uncommon, can occur and should be discussed fully during a pre-treatment consultation. Patients should always ensure their practitioner holds appropriate qualifications and operates within a regulated setting.

Is there an ideal age to consider sub-epidermal aesthetic treatments?

There is no single "ideal" age, as biological ageing progresses differently in every individual and is influenced by genetics, lifestyle, skin type, and sun exposure history. Some patients in their thirties notice early signs of dermal ageing and choose to explore preventive or early-intervention treatments, while others address concerns that have developed over many years. What matters most is that the decision is made based on individual assessment and personal, well-informed choice — not age alone. A qualified practitioner can help determine whether treatment is appropriate and what options may be suitable.

What should I ask during an aesthetic consultation?

A useful starting point is to be open about your concerns, what you have noticed changing, and what outcome you hope to achieve. Questions worth asking include: what is causing the changes I am noticing? What treatments might be relevant for my concerns? What are the realistic outcomes and limitations? What are the risks? How many sessions might be involved, and how long might results last? Understanding the practitioner's qualifications and approach to safety is also important. A good consultation should feel educational, unpressured, and tailored to you as an individual.

The biology of skin ageing makes clear that lasting structural change requires more than surface-level intervention. The dermis and sub-dermal layers — where collagen is synthesised and degraded, where elastin fibres lose their resilience, and where hyaluronic acid diminishes over time — are where the most significant changes in facial appearance originate. Because the epidermis acts as a protective barrier, professional treatments capable of delivering their effects below this layer represent a fundamentally different category of intervention to topical skincare.

This does not mean topical products lack value — consistent, evidence-based skincare remains an important component of any long-term skin health strategy. Rather, it means that for patients noticing structural changes in skin firmness, volume, or deeper wrinkle formation, a conversation with a qualified aesthetic practitioner may be a valuable next step in understanding what options are available to them.

Informed decision-making, balanced expectations, and individual assessment are the cornerstones of responsible aesthetic practice. Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation.

If you have questions about skin ageing or aesthetic treatments, we would encourage you to seek personalised advice from a qualified practitioner who can assess your individual circumstances and discuss appropriate options.

This article is for general educational purposes only and does not constitute personalised medical or aesthetic advice. Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation.